Trademark: 88255707
Word
INAGENE DIAGNOSTICS
Status Date
Wednesday, April 24, 2024
Filing Date
Wednesday, January 9, 2019
41 Providing online non-downloadable audio and video recordings containing information in the field of medical testing services, namely, genetic testing and genetic screening over a global computer network
35 Advertising the goods and services of others focused on the application of personal genetic information for pain management, mental health and other comorbid conditions; developing promotional campaigns focused on the application of personal genetic information for pain management, mental health and other comorbid conditions, and marketing services, namely, marketing consultancy for businesses in the field of personal genetic information for pain management, mental health and other comorbid conditions, all the foregoing not including veterinary or plant applications
44 Medical diagnostic testing services and providing medical information in the form of personalized reports online in the field of genetic testing for medical purposes; providing clinical laboratory testing services, namely, personalized medical tests based on the assessment, development and application of human genomic discoveries in the medical industry; online medical testing services, namely, genetic testing and genetic screening; Medical information services, namely, providing personalized information online in the field of genetic testing for medical purposes; medical information services, namely, reporting and providing feedback to patients and healthcare professionals on pharmacogenetic testing service results and relevance to medical and nutritional treatments, namely, personal genetic information for pain management, mental health and other comorbid conditions and for understanding individual responses to medication, all the foregoing not including veterinary or plant applications; medical information services, namely, analyzing pharmacogenetic testing service results and relevance to medical and nutritional treatments, namely, the interaction between personal genetic information and pharmaceuticals, all the foregoing not including veterinary or plant applications; medical information services, namely, preparation of reports on pharmacogenetic testing service results and relevance to medical and nutritional treatments, namely, analyzing individual pharmacogenetics and the interaction between personal genetic information and pharmaceuticals, all the foregoing not including veterinary or plant applications
42 Genetic testing and genetic screening services for scientific research purposes; scientific research in the fields of genomics and genetics; scientific research in the application of personal genetic information with respect to medical or nutritional treatments, pharmaceuticals and clinical trials; providing genetic-based nutritional and pharmaceutical research information via the internet and via printed publications; providing clinical laboratory testing services, namely, pharmacogenetic tests, gene sequencing-based tests and genotyping based on the assessment, development and application of human genomic discoveries in the pharmaceutical, informatics and human clinical diagnostic industries, all the foregoing not including veterinary or plant applications; medical research in the fields of genomics and genetics; providing genetic-based medical research information via the internet and via printed publications; medical research in the fields of pharmacogenomics and pharmacogenetics; providing temporary use of on-line non-downloadable software applications related to medical conditions addressed by medical testing services, namely, platform as a service (PAAS) featuring computer software and mobile device applications for accessing information in the field of pain management, mental health and other comorbid conditions; providing genetic testing information for patients and healthcare professionals via an internet website portal; online services relating to medical testing services, namely, providing genetic testing and genetic screening information for patients and healthcare professionals via an internet website portal
Mar 25, 2019
Non-Final Action Written
Jan 12, 2019
New Application Entered
Jan 30, 2019
New Application Office Supplied Data Entered
Mar 25, 2019
Assigned To Examiner
Mar 25, 2019
Non-Final Action E-Mailed
Mar 25, 2019
Notification Of Non-Final Action E-Mailed
Aug 2, 2019
Teas Response To Office Action Received
Aug 2, 2019
Correspondence Received In Law Office
Aug 3, 2019
Teas/Email Correspondence Entered
Aug 14, 2019
Examiners Amendment -Written
Aug 14, 2019
Examiners Amendment E-Mailed
Aug 14, 2019
Notification Of Examiners Amendment E-Mailed
Aug 14, 2019
Examiner's Amendment Entered
Sep 24, 2019
Examiners Amendment And/Or Priority Action - Completed
Sep 24, 2019
Combined Examiner's Amendment/Priority Action Automatic Entry
Sep 24, 2019
Examiner's Amendment/Priority Action E-Mailed
Sep 24, 2019
Notification Of Examiner's Amendment/Priority Action E-Mailed
Oct 17, 2019
Teas Response To Office Action Received
Oct 23, 2019
Assigned To Lie
Oct 30, 2019
Correspondence Received In Law Office
Oct 30, 2019
Teas/Email Correspondence Entered
Nov 1, 2019
Suspension Letter Written
Nov 1, 2019
Letter Of Suspension E-Mailed
Nov 1, 2019
Notification Of Letter Of Suspension E-Mailed
May 1, 2020
Suspension Inquiry Written
May 1, 2020
Inquiry To Suspension E-Mailed
May 1, 2020
Notification Of Inquiry As To Suspension E-Mailed
Nov 2, 2020
Teas Response To Suspension Inquiry Received
Nov 29, 2020
Assigned To Lie
Dec 3, 2020
Correspondence Received In Law Office
Dec 3, 2020
Teas/Email Correspondence Entered
Dec 3, 2020
Suspension Letter Written
Dec 3, 2020
Letter Of Suspension E-Mailed
Dec 3, 2020
Notification Of Letter Of Suspension E-Mailed
Jun 3, 2021
Report Completed Suspension Check Case Still Suspended
Dec 6, 2021
Suspension Letter Written
Dec 6, 2021
Letter Of Suspension E-Mailed
Dec 6, 2021
Notification Of Letter Of Suspension E-Mailed
Dec 6, 2021
Suspension Checked - To Attorney For Action
Mar 7, 2022
Assigned To Examiner
Jun 24, 2022
Suspension Checked - To Attorney For Action
Aug 6, 2022
Suspension Inquiry Written
Aug 6, 2022
Inquiry To Suspension E-Mailed
Aug 6, 2022
Notification Of Inquiry As To Suspension E-Mailed
Feb 6, 2023
Teas Response To Suspension Inquiry Received
Feb 14, 2023
Assigned To Lie
Feb 16, 2023
Correspondence Received In Law Office
Feb 16, 2023
Teas/Email Correspondence Entered
Jun 6, 2023
Priority Action Written
Jun 6, 2023
Priority Action E-Mailed
Jun 6, 2023
Notification Of Priority Action E-Mailed
Jan 19, 2024
Abandonment - Failure To Respond Or Late Response
Jan 19, 2024
Abandonment Notice E-Mailed - Failure To Respond
Jan 22, 2024
Abandonment Notice E-Mailed - Failure To Respond
Mar 4, 2024
Teas Response To Office Action Received
Mar 4, 2024
Teas Petition To Revive Received
Apr 8, 2024
Assigned To Petition Staff
Apr 10, 2024
Petition Granted - Response Received
Apr 10, 2024
Correspondence Received In Law Office
Apr 10, 2024
Teas/Email Correspondence Entered
Apr 10, 2024
Notice Of Revival - E-Mailed
Apr 24, 2024
Approved For Pub - Principal Register
Trademark Alertz updated from USPTO on 2030-01-24
